Issue Special Issue 1/2006
Content (5 Articles)
Introduction
Simulating the Real World of Antihyperglycaemic Therapies in Type 2 Diabetes
Amanda I. Adler
Original Research Article
A Model of Long-term Metabolic Progression of Type 2 Diabetes Mellitus for Evaluating Treatment Strategies
Adrian Bagust, Marc Evans, Sophie Beale, Philip D. Home, Andrew S. Perry, Murray Stewart
Original Research Article
Cost-effectiveness of Rosiglitazone Combination Therapy for the Treatment of Type 2 Diabetes Mellitus in the UK
Sophie Beale, Adrian Bagust, Arran T. Shearer, Alan Martin, Lisa Hulme
Original Research Article
Cost-effectiveness of Rosiglitazone Oral Combination for the Treatment of Type 2 Diabetes in Germany
Arran T. Shearer, Adrian Bagust, Andreas Liebl, Oliver Schoeffski, Anita Goertz
Original Research Article
Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain
Arran T. Shearer, Adrian Bagust, F. Javier Ampudia-Blasco, Belén Martínez-Lage Álvarez, Isabel Pérez Escolano, Gonzalo París